Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population

Saved in:
Bibliographic Details
Published in:Bone marrow transplantation (Basingstoke) 2021-07, Vol.56 (7), p.1761-1763
Main Authors: Shapiro, Lauren C., Mustafa, Jennat, Lombardo, Amanda, Khatun, Fariha, Joseph, Felisha, Gillick, Kailyn, Naik, Anjali, Elkind, Richard, Abreu, Michelly, Fehn, Karen, de Castro, Alyssa, Pradhan, Kith, Binakaj, Donika, Nelson, Randin, Paroder, Monika, Uehlinger, Joan, Gritsman, Kira, Alejandro Sica, R., Kornblum, Noah, Shastri, Aditi, Mantzaris, Ioannis, Bachier-Rodriguez, Lizamarie, Verma, Amit, Braunschweig, Ira, Goldfinger, Mendel
Format: Article
Language:English
Subjects:
692/699/1541/1990/291/1621/1915
Aged patients
B-cell lymphoma
Cancer
Cell Biology
Correspondence
Drug therapy
Hematology
Internal Medicine
Lymphocytes B
Lymphoma
Lymphomas
Medicine
Medicine & Public Health
Patient outcomes
Public Health
Relapse
Stem Cells
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0268-3369
1476-5365
DOI:10.1038/s41409-021-01280-3